Product
XJ101
Aliases
XJ101 for Injection
1 clinical trial
1 indication
Clinical trial
A Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Immunogenicity of XJ101 in Chinese Healthy SubjectsStatus: Active (not recruiting), Estimated PCD: 2024-04-28